| ID | 31826 |
| JaLCDOI | |
| FullText URL | |
| Author |
Fujikawa, Tatsuya
|
| Abstract | Serum des-gamma-carboxy prothrombin (DCP) is commonly used to detect hepatocellular carcinoma (HCC). This review focuses on the clinical features of DCP-positive HCC and the molecular function of DCP in HCC. DCP-positive HCC demonstrates more aggressive clinicopathological features than DCP-negative HCC. Analysis of the biological effects of DCP revealed that DCP acts as a growth factor in both an autocrine and paracrine manner. DCP stimulates HCC cell proliferation through the Met-Janus kinase 1-signal transducer and activator of transcription 3 signaling pathway, whereas for vascular endothelial cells, it stimulates cell proliferation and migration through the kinase insert domain receptor-phospholipase C-gamma-mitogen-activated protein kinase signaling pathway. |
| Keywords | des-gamma-carboxy prothrombin
hepatocellular carcinoma
signaling pathway
cell proliferation
angiogenesis
|
| Amo Type | Review
|
| Publication Title |
Acta Medica Okayama
|
| Published Date | 2009-12
|
| Volume | volume63
|
| Issue | issue6
|
| Publisher | Okayama University Medical School
|
| Start Page | 299
|
| End Page | 304
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| Content Type |
Journal Article
|
| language |
English
|
| File Version | publisher
|
| Refereed |
True
|
| PubMed ID | |
| Web of Science KeyUT |